{"id":"5fa494d1-6a87-410c-bb5b-2354cb859951","kind":"news","code":"5fa494d1-6a87-410c-bb5b-2354cb859951","name":"Anda Biotechnology raises tens of millions of RMB in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"安达生物完成数千万元A轮融资","eventDate":"2025-03-24T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:18:29.307Z","englishUpdatedAt":"2026-10-15T18:29:25.443Z","reviewedAt":"2026-10-15T18:29:25.443Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"4fbb95f92e81f62e808db961646e0a506909a4ef7e44f7a888874155e78a41f6","companyId":"64d65934-0d53-4cdb-badb-47b03b82f51b","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"64d65934-0d53-4cdb-badb-47b03b82f51b","kind":"companies","code":"UB-C6779","name":"Anda Biotechnology","nameBasis":"transliterated","summary":"Personalized tumor neoantigen therapies and AI-assisted drug development","description":"","country":"China","category":null,"originalName":"安达生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:24:40.931Z","reviewedAt":"2026-10-20T18:24:40.931Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"9a37202fe58194d6131c5821b131d883fee0543deff2a7f69d004e35addb980b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C6779"},{"id":"f9499927-e1e8-44fe-84bd-1106d8edca54","kind":"institutions","code":"UB-I5183","name":"Botong Venture Capital","nameBasis":"transliterated","summary":"Botong Venture Capital is a corporate venture capital investor, investing in technology startups.","description":"Botong Venture Capital is a corporate venture capital investor, investing in technology startups.","country":"United States","category":null,"originalName":"博通创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T06:00:17.030Z","englishUpdatedAt":"2026-10-20T18:27:14.275Z","reviewedAt":"2026-10-20T18:27:14.275Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"1af2b01ed3d8d4a60189b67fa5ea39dd72908f2488de66eb48742a8fd957c542","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/botong-venture-capital"},{"id":"2202ba9b-da56-456a-b844-a85b488b787a","kind":"institutions","code":"UB-I5159","name":"Defengjielongmai Fund","nameBasis":"transliterated","summary":"Defengjie Longmai Fund, a China-based equity investment firm focused on startup- to growth-stage technology ventures.","description":"Defengjie Longmai Fund, a China-based equity investment firm focused on startup- to growth-stage technology ventures.","country":null,"category":null,"originalName":"德丰杰龙脉基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:46:24.012Z","englishUpdatedAt":"2026-10-15T21:38:48.451Z","reviewedAt":"2026-10-15T21:38:48.451Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a3c5484542af6ab72cf87d5d46adda491864a5c0961d9d2c9eeb962b3a3c7a4","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/defengjielongmai-fund"},{"id":"94731abd-ce30-4571-a03f-107ff8ec2582","kind":"institutions","code":"UB-I1716","name":"Liding Capital","nameBasis":"transliterated","summary":"Liding Capital, a mainland Chinese private equity investment firm investing in growth- to mature-stage company equity.","description":"Liding Capital, a mainland Chinese private equity investment firm investing in growth- to mature-stage company equity.","country":null,"category":null,"originalName":"力鼎资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:36:27.114Z","englishUpdatedAt":"2026-10-15T21:37:02.723Z","reviewedAt":"2026-10-15T21:37:02.723Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5a9d932945cffe57f5d8532765ef806aed12d4971ee6d499b216d496d41b38d3","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/liding-capital"},{"id":"540702c7-a338-4d35-b996-a1dd65f8bcb2","kind":"institutions","code":"UB-I1483","name":"Puxin Capital","nameBasis":"transliterated","summary":"Puxin Capital, a Chinese venture capital firm investing in technology projects.","description":"Puxin Capital, a Chinese venture capital firm investing in technology projects.","country":null,"category":null,"originalName":"浦信资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.053Z","englishUpdatedAt":"2026-10-15T20:58:45.464Z","reviewedAt":"2026-10-15T20:58:45.464Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"176d1f1c43d770f03a383b246d89f825885b4995be91c35ebe6cc756acbcf499","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/puxin-capital"},{"id":"9194bb19-82f1-4046-b8b5-3c9cddd3f766","kind":"institutions","code":"UB-I5189","name":"Sinanyuanke","nameBasis":"transliterated","summary":"Sinanyuanke, a venture capital firm focused on technology investments.","description":"Sinanyuanke, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"司南园科","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:27.021Z","englishUpdatedAt":"2026-10-15T17:35:39.397Z","reviewedAt":"2026-10-15T17:35:39.397Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"1d215d400c176309355be3991985031b50e408f34d8cc1a7b6b5ad7155b098aa","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/sinanyuanke"}],"path":"/news/5fa494d1-6a87-410c-bb5b-2354cb859951","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Anda Biotechnology","path":"/companies/UB-C6779"}},"canonical":"https://uniquebase.ai/news/5fa494d1-6a87-410c-bb5b-2354cb859951"}